Radiopharmaceuticals: Technologies and Global Markets

News provided by

Dec 18, 2014, 11:27 ET

NEW YORK, Dec. 18, 2014 /PRNewswire/ -- This BCC Research report covers present and future strategies within the radiopharmaceuticals market along with the invention of the market, the setbacks and the needs of the market. A detailed analysis of the radiopharmaceuticals industry structure has been conducted. CAGR projections are presented from 2014 through 2019.

Use this report to:
- Learn about the innovations in antibody engineering, recombinant DNA technology, conjugation chemistry and nanotechnology that are providing new approaches to the
delivery of radionuclides to cancer cells.
- Examine the invention of the market, the setbacks and the needs of the radiopharmaceuticals market.
- Gain information on the strengths and weaknesses of each type/technology in light of the new technologies, growing competition and changing customer needs in
radiopharmaceuticals market.

Highlights
- The global market for radiopharmaceuticals in 2012 was about $3.8 billion and $3.9 billion in 2013. The estimated market for the year 2014 is nearly $4.4 billion and this figure is forecast to expand through 2019 at a projected compound annual growth rate (CAGR) of 8%, approaching $6.4 billion.
- The North American market is expected to grow from $2.4 billion in 2014 to about $3.8 billion in 2019 at an estimated CAGR of 9.2% from 2014 to 2019.
- European market is expected to reach about $1.2 billion in 2014 and $1.6 billion by 2019, with a CAGR of 6.8% from 2014 to 2019.

INTRODUCTION

STUDY OBJECTIVES
Radiopharmaceuticals play an important role in the medical, pharmaceutical, diagnostic, biotechnology and life sciences industries. A radiopharmaceutical is a radioactive drug used in diagnostics as well as in the treatment of certain medical problems/diseases. The radiopharmaceuticals market is broadly segmented into two parts, namely, the diagnostic and therapeutic market. North America holds the largest share in the global radiopharmaceuticals market. The objective behind undertaking this study is to provide a synopsis of the current and future characteristics of the global market for radiopharmaceuticals. The notion behind the report is to present a comprehensive analysis of and the future direction for radiopharmaceuticals as an important tool for diagnostics as well as treatment for innumerable diseases.

The report reconnoiters present and future strategies within the radiopharmaceuticals market. The invention of the market, the setbacks and the needs of the market are
discussed in this report. A detailed analysis of the radiopharmaceuticals industry structure has been conducted. Revenues are broken down by the region. Sales figures
are given for 2012 and 2013, estimated for 2014, and projected for 2019.

REASONS FOR DOING THIS STUDY
Radiopharmaceuticals are used extensively in medicine, biotechnology and pharmaceutical research. Over the past few years, a number of techniques have been developed utilizing radiopharmaceuticals for the treatment and diagnosis of aliments. Extensive research in the field of this type of drugs has exposed specific functionality in modern medicine. Newer treatments for various maladies have now begun to explore the advantages of radiopharmaceuticals. This has led to the steady market for them.

R&D spending along with increasing competition, patent expiries and new technologies are directing this market. Advancements and new product launches have influenced
market growth in the near future. This study looks at almost all the systems affected by these factors. Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type/technology in light of the new technologies, growing competition and changing customer needs.

CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE
This study contributes to the areas of market growth in radiopharmaceuticals manufacturers/generators and users. Pharmaceutical biotechnical companies, research
institutes and physicians will find this study to be of interest.

SCOPE OF THE STUDY
The scope of this study encompasses radiopharmaceuticals in pharmaceutical markets. BCC Research analyzes each market and its applications, regulatory environment,
technology, market projections and market shares. The report also covers the brachytherapy seeds. Technological issues include the latest trends and developments. The emerging market for radiopharmaceuticals includes countries like India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.

METHODOLOGY
Both primary and secondary research methodologies were used in preparing this study. BCC Research conducted a comprehensive literature search, which included technical
newsletters and journals and many other sources. Data were collected through interviews and correspondence with manufacturers of radiopharmaceutical technical
experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.
Read the full report: http://www.reportlinker.com/p02374323-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001